Lista de obras -

A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome.

artículo científico publicado en 2013

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study

artículo científico publicado en 2010

Acid-related disorders

artículo científico publicado en 2008

Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial

artículo científico publicado en 2012

Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort

artículo científico publicado en 2018

Burden of upper gastrointestinal symptoms in patients receiving low-dose acetylsalicylic acid for cardiovascular risk management: a prospective observational study

artículo científico publicado en 2013

Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria.

artículo científico publicado en 2011

Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome.

artículo científico publicado en 2018

Danish national guideline: Diagnosis and treatment of Irritable Bowel Syndrome

artículo científico publicado en 2017

Diagnosis and treatment of Helicobacter pylori infection

artículo científico publicado el 1 de abril de 2011

Diagnostic approach to dyspepsia

artículo científico publicado en 2004

Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse ⬇️

artículo científico publicado el 1 de octubre de 2010

Dyspepsia as an adverse effect of drugs

artículo científico publicado en 2010

Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease

artículo científico publicado en 2005

Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment

artículo científico publicado en 2006

Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial ⬇️

artículo científico publicado el 28 de marzo de 2011

Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment

artículo científico publicado en 2021

Faecal microbiota transplantation for the treatment of bowel disease ⬇️

artículo científico publicado en 2017

Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients

artículo científico publicado en 2003

H(2) receptor antagonists and prokinetics in dyspepsia: a critical review

artículo científico publicado en 2002

Health-related quality of life scores changes significantly within the first three months after hernia mesh repair

artículo científico publicado en 2014

Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease

artículo científico publicado en 2012

Metronidazole Therapy for Treating Dientamoebiasis in Children Is Not Associated With Better Clinical Outcomes: A Randomized, Double-Blinded and Placebo-Controlled Clinical Trial

article published in 2014

Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data

artículo científico publicado en 2007

New hope for functional dyspepsia?

artículo científico publicado en 2012

On-demand therapy for gastroesophageal reflux disease

artículo científico publicado en 2007

Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota

artículo científico publicado en 2016

Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care

artículo científico publicado en 2013

Perceptions and beliefs concerning gastroesophageal reflux disease: physicians and patients disagree

artículo científico publicado en 2007

Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.

artículo científico publicado en 2017

Prevalence, incidence, and risk factors of intestinal parasites in Danish primary care patients with irritable bowel syndrome

artículo científico publicado en 2013

Proton pump inhibitors--are they really harmless?2

artículo científico publicado el 29 de septiembre de 2003

Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy

artículo científico publicado en 2009

Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure

artículo científico publicado en 2016

Review article: Single subject trials as a research instrument in gastrointestinal pharmacology

artículo científico publicado en 2002

Screening instruments for anxiety and depression in patients with irritable bowel syndrome are ambiguous

artículo científico publicado en 2014

Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15,000 Australian adults

artículo científico publicado en 2003

Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model

artículo científico publicado en 2008

Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome?

scientific article published on 21 May 2019

Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment

artículo científico publicado en 2013

The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age.

artículo científico publicado en 2013

The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study

artículo científico publicado en 2014

The quality of colonoscopy in Denmark. Results from a European quality study

artículo científico publicado en 2005

Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.

artículo científico publicado en 2012

Treatment of hospitalized patients in a medical department with acid-suppressing medication

artículo científico publicado en 2004

Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel

artículo científico publicado en 2014

Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study

artículo científico publicado en 2014

What makes individuals with gastroesophageal reflux disease dissatisfied with their treatment?

scientific article published on 13 March 2009

Work productivity improvement after acid suppression in patients with uninvestigated dyspepsia.

artículo científico publicado en 2012

[Diagnostic strategy in patients suspected of irritable bowel syndrome] ⬇️

scientific article published on 01 February 2014

[Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].

artículo científico publicado en 2005

Lista de obras de

A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome.

Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study

Acid-related disorders

Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial

Antibiotics: a risk factor for irritable bowel syndrome in a population-based cohort

Burden of upper gastrointestinal symptoms in patients receiving low-dose acetylsalicylic acid for cardiovascular risk management: a prospective observational study

Characteristics of acute pain attacks in patients with irritable bowel syndrome meeting Rome III criteria.

Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome.

Danish national guideline: Diagnosis and treatment of Irritable Bowel Syndrome

Diagnosis and treatment of Helicobacter pylori infection

Diagnostic approach to dyspepsia

Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse ⬇️

Dyspepsia as an adverse effect of drugs

Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease

Effect of rabeprazole and omeprazole on the onset of gastro-oesophageal reflux disease symptom relief during the first seven days of treatment

Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: A randomized, placebo-controlled trial ⬇️

Expansion and persistence of antibiotic-specific resistance genes following antibiotic treatment

Faecal microbiota transplantation for the treatment of bowel disease ⬇️

Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients

H(2) receptor antagonists and prokinetics in dyspepsia: a critical review

Health-related quality of life scores changes significantly within the first three months after hernia mesh repair

Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease

Metronidazole Therapy for Treating Dientamoebiasis in Children Is Not Associated With Better Clinical Outcomes: A Randomized, Double-Blinded and Placebo-Controlled Clinical Trial

Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data

New hope for functional dyspepsia?

On-demand therapy for gastroesophageal reflux disease

Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota

Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care

Perceptions and beliefs concerning gastroesophageal reflux disease: physicians and patients disagree

Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.

Prevalence, incidence, and risk factors of intestinal parasites in Danish primary care patients with irritable bowel syndrome

Proton pump inhibitors--are they really harmless?2

Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy

Psychometric evaluation of a daily gastro-oesophageal reflux disease symptom measure

Review article: Single subject trials as a research instrument in gastrointestinal pharmacology

Screening instruments for anxiety and depression in patients with irritable bowel syndrome are ambiguous

Symptom clustering in subjects with and without diabetes mellitus: a population-based study of 15,000 Australian adults

Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model

Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome?

Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment

The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age.

The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a population-based case-control study

The quality of colonoscopy in Denmark. Results from a European quality study

Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.

Treatment of hospitalized patients in a medical department with acid-suppressing medication

Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel

Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study

What makes individuals with gastroesophageal reflux disease dissatisfied with their treatment?

Work productivity improvement after acid suppression in patients with uninvestigated dyspepsia.

[Diagnostic strategy in patients suspected of irritable bowel syndrome] ⬇️

[Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].